Cwm LLC Acquires 4,520 Shares of Globe Life Inc. $GL

Cwm LLC boosted its stake in Globe Life Inc. (NYSE:GL) by 11.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 43,745 shares of the company’s stock after purchasing an additional 4,520 shares during the quarter. Cwm LLC’s holdings in Globe Life were worth $6,254,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in GL. Pacer Advisors Inc. boosted its stake in shares of Globe Life by 29.8% during the 3rd quarter. Pacer Advisors Inc. now owns 8,776 shares of the company’s stock valued at $1,255,000 after purchasing an additional 2,017 shares in the last quarter. Inspire Investing LLC purchased a new stake in Globe Life in the third quarter worth about $1,062,000. World Investment Advisors boosted its position in Globe Life by 3.7% during the 3rd quarter. World Investment Advisors now owns 3,189 shares of the company’s stock valued at $456,000 after acquiring an additional 114 shares in the last quarter. Parcion Private Wealth LLC purchased a new position in shares of Globe Life during the 3rd quarter worth approximately $230,000. Finally, Security Financial Services INC. bought a new position in shares of Globe Life in the 3rd quarter worth approximately $367,000. 81.61% of the stock is currently owned by institutional investors.

Globe Life Stock Down 0.2%

NYSE:GL opened at $141.45 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a market cap of $11.26 billion, a P/E ratio of 10.25 and a beta of 0.48. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $147.83. The firm has a 50-day simple moving average of $135.12 and a two-hundred day simple moving average of $134.34.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the prior year, the firm posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. Analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Monday, January 5th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Monday, January 5th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is presently 7.83%.

Insider Buying and Selling at Globe Life

In other news, CEO Frank M. Svoboda sold 9,379 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,036,943.24. This represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.97% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on GL shares. Keefe, Bruyette & Woods upped their price target on Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Truist Financial upped their target price on shares of Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Morgan Stanley reissued an “overweight” rating and set a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. TD Cowen boosted their price objective on shares of Globe Life from $182.00 to $199.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, Piper Sandler restated an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $164.89.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.